Term
"caines" with one "i"s
cocaine, benzocaine, procaine, propoxycaine, tetracaine |
|
Definition
|
|
Term
"caines" with two "i"s
lidocaine, mepivacaine, bupivacaine, ropivacaine, etidocaine, prilocaine |
|
Definition
|
|
Term
| norepinephrine, epinephrine, phenylephrine, felypressin |
|
Definition
| vasoconstrictors adjunct to local anesthetics to prolong duration |
|
|
Term
|
Definition
| Most superficial afferent neurons block |
|
|
Term
|
Definition
| in the muscle, blocks more neurons thatn surface |
|
|
Term
|
Definition
| Blocks nerve trunks and not just individual nerves |
|
|
Term
|
Definition
| self explanatory, blocks everything below where the anesthesia is injected in the spine |
|
|
Term
Type A Nerve fiber
Type alpha Nerve Fiber |
|
Definition
| Motor, proprioception. Biggest diameter >12. Least sensitive to block, fastest conduction. |
|
|
Term
|
Definition
| Touch and pressure, 5-12 diameter |
|
|
Term
|
Definition
| Muscle Spindles 3-6 micrometer diameter |
|
|
Term
|
Definition
| Pain, Temperature 1-4 diameter. Slowest conduction but highest sensitivity AMONG TYPE A NERVE FIBERS |
|
|
Term
|
Definition
| Prganglion, sympathetic. Lower than 3 diameter. |
|
|
Term
| Type C; Dorsal Root sympathetic |
|
Definition
| Pain (0.4-1.2), Postganglionic sympathetic. (0.3-1.3 |
|
|
Term
|
Definition
| Used as a preservative for local anesthetics. Reason why some anesthetics caused allergic reactions |
|
|
Term
| Atypical Pseudocholinesterase |
|
Definition
| A genetic variation of an enzyme |
|
|
Term
|
Definition
| Prilocaine, lidocaine, benzocaine metabolites can cause this |
|
|
Term
| General Anesthesia Induction |
|
Definition
| Time it takes to achieve surgical anesthesia |
|
|
Term
| General Anesthesia Maintenance |
|
Definition
| Keeping patient at stable state of surgical anesthesia |
|
|
Term
| General Anesthesia Emergence |
|
Definition
| Recovery from general anesthesia |
|
|
Term
|
Definition
| Might still feel pain but brain cant tell wherer its coming from. Patient awake and consicous |
|
|
Term
|
Definition
| Inhibits inhibitory mechanism first causing respiration, BP, HR to increase and muscles to twitch |
|
|
Term
|
Definition
| The stage where you want to maintain the patient |
|
|
Term
|
Definition
| Too much anesthetic can cause death |
|
|
Term
| MAC or minimum alveolar concentratoin |
|
Definition
| Amount of gas that knocks out 50% of the patient |
|
|
Term
|
Definition
| Combination of drag that adds up to full mac value |
|
|
Term
|
Definition
| General anestehtic inhalation agents |
|
|
Term
|
Definition
| Fluorinated hydrocarbon as general anesthetic inhalation agent |
|
|
Term
|
Definition
| Fluorinated hydrocarbon as general anesthetic inhalation agent |
|
|
Term
|
Definition
| Fluorinated hydrocarbon as general anesthetic inhalation agent |
|
|
Term
|
Definition
| Only effective drug to interfere with excitation contraction complement |
|
|
Term
|
Definition
IV general anesthetic agent that enhance inhibitory GABA neurotransmission
no analgesia or skeletal muscle relaxation (combine opioid) |
|
|
Term
|
Definition
IV general anesthetic agent that enhance inhibitory GABA neurotransmission
no analgesia or skeletal muscle relaxation (combine opioid) |
|
|
Term
|
Definition
IV general anesthetic agent that enhance inhibitory GABA neurotransmission
no analgesia or skeletal muscle relaxation (combine opioid) |
|
|
Term
|
Definition
IV general anesthetic agent that enhance inhibitory GABA neurotransmission. This is a benzodiazepine
no analgesia or skeletal muscle relaxation (combine opioid) |
|
|
Term
|
Definition
| IV general anesthetic agent that inhibit excitatory NMDA neurotransmission. Dissociate anesthsia with analgesia |
|
|
Term
| droperidol/fentanyl (Innovar®) |
|
Definition
| IV general anesthetic agent - neuroleptanalgesia (neuroleptic and analgesic drug) |
|
|
Term
|
Definition
| Neurotransmitter released from pain signals |
|
|
Term
|
Definition
| Antidotal Therapy for morphine toxicity (short duration) |
|
|
Term
|
Definition
| Antidotal Therapy for morphine toxicity (long acting) |
|
|
Term
|
Definition
| Phenanthrenes, Opium alkaloids |
|
|
Term
| Hydromorphone/codone: oxymorphone/codone - Diacetylmrphine |
|
Definition
| Semisynthetic opiate drugs |
|
|
Term
|
Definition
| Phenylptylamines. 3x morphine potency |
|
|
Term
|
Definition
| Phenylptylamines - treatment of addiction |
|
|
Term
|
Definition
| phenylpiperidines: 1/8 x morphine potency |
|
|
Term
|
Definition
| phenylpiperidines: 80x morphine potency |
|
|
Term
|
Definition
| phenylpiperidines: 10x morphine potencyt |
|
|
Term
|
Definition
| phenylpiperidinesL 500x morphine potnecy |
|
|
Term
|
Definition
| phenylpiperidines 8000x morphine opotency - for bears and big animals |
|
|
Term
|
Definition
| endogenous opioid peptides - brain and spinal cord neurotransmitter; also releaed from adrenal medulla as a hormione. mu and delta receptors |
|
|
Term
|
Definition
|
|
Term
|
Definition
| endogenous opioid peptides, brain neurotransmitter and pituitary hormone. Mu and epsalon. |
|
|
Term
|
Definition
| endogenous opioid peptides . Brain and spinal cord neurtransmitter. exclusively kappa |
|
|
Term
|
Definition
| Brain neurotransmitter. Mu |
|
|
Term
|
Definition
| for morphine and most clinical narcotic analgesics; thought to produce strongest analgesia |
|
|
Term
|
Definition
| for mixed agonist-antagonist |
|
|
Term
|
Definition
| agonist under development. better for neuropathetic pain. and less addiction etc. |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Mixed antagonist(mu) - agonist(kappa). |
|
|
Term
|
Definition
| Mixed antagonist(mu) - agonist(kappa). |
|
|
Term
|
Definition
| Mixed antagonist(mu) - agonist(kappa). |
|
|
Term
|
Definition
| Ergot derived prophylactic agent for migraines. prevent initial 5HT induced vasoconstriction |
|
|
Term
|
Definition
| nonspecific vascular smooth muscle stimulation to reverse reactive vasodilation |
|
|
Term
| Sumatriptan, rizatriptan, eletriptan |
|
Definition
| Stimulation of 5HT to promote vasoconstriction |
|
|
Term
| Ascending Reticular activation system (ARAS) or reticular formation |
|
Definition
| sends message to cortex from peripheral afferent neurons |
|
|
Term
|
Definition
| A thiobarbiturate. Ultra short acting barbiturate sedative |
|
|
Term
|
Definition
| short-to intermidiate acting oxybarbiturate |
|
|
Term
|
Definition
| short-to intermidiate acting oxybarbiturate |
|
|
Term
|
Definition
| short-to intermidiate acting oxybarbiturate |
|
|
Term
|
Definition
| long-acting (oxy)barbiturate |
|
|
Term
|
Definition
| long-acting (oxy)barbiturate : prodrug of phenobarbital |
|
|
Term
| Ultrashort acting barbiturates |
|
Definition
| Useful for IV general anesthetics |
|
|
Term
| short-tointermediat acting barbiturates |
|
Definition
|
|
Term
| long-acting anticonvulsants barbiturates |
|
Definition
|
|
Term
| acute intermittent porphyria |
|
Definition
| Only absolute contraindication of barbiturates. Porphyrins, which are needed for hemoglobin are created in excess and stored in tissues. |
|
|
Term
|
Definition
| antagonizes benzodiazepines and imidazopyridines |
|
|
Term
|
Definition
| agonist at melatonin 1 and 2. no direct effect on gaba. only non scheduled rx to treat insomnia |
|
|
Term
|
Definition
| Centrally-Acting Muscle Rexalants -drugs that likely facilitate inhibitory GABAA neurotransmission |
|
|
Term
|
Definition
| Centrally-Acting Muscle Rexalants -drugs that likely facilitate inhibitory GABAA neurotransmission |
|
|
Term
|
Definition
| Centrally-Acting Muscle Rexalants -drugs that likely facilitate inhibitory GABAA neurotransmission |
|
|
Term
|
Definition
| Centrally-Acting Muscle Rexalants -drugs that likely facilitate inhibitory GABAA neurotransmission |
|
|
Term
|
Definition
| Centrally-Acting Muscle Rexalants -drugs that stimulate inhibitory GABAB receptors |
|
|
Term
|
Definition
| Centrally-Acting Muscle Rexalants - drugs that facilitate inhibitory 2 adrenergic neurotransmission |
|
|
Term
|
Definition
Centrally-Acting Muscle Rexalants peripherally-acting muscle relaxant
competitive antagonism of ryanodine receptor to interfere with calcium release and excitation-contraction coupling (ECC) in skeletal muscle |
|
|
Term
| Rate limiting step of ethanol metabolism |
|
Definition
|
|
Term
|
Definition
| 3xnormal rate of EtOH to acetaldehyde. 80% in asians |
|
|
Term
|
Definition
| near inactive form or acetaldehyde dehydrogenase. 60% of asians |
|
|
Term
|
Definition
| acetaldehyde dehydrogenase inhibitor. aversion therapy. |
|
|
Term
| Greseofulvin, metronidazole, sulfonylureas. |
|
Definition
| has signifianct disulfiram like action |
|
|
Term
|
Definition
| Circulatory, respiratory depression, coma, death |
|
|
Term
|
Definition
| Stupor, confused, unable to stay awake |
|
|
Term
|
Definition
| Depressed sensory and motor capability, difficulty staying awake, really slurred speech, double vision |
|
|
Term
|
Definition
| Impairment of balance, movement, judgment and perception; blurred vision; ataxia |
|
|
Term
|
Definition
| Slow reaction time, impaired motor function, slurred speech |
|
|
Term
|
Definition
| Lowered alertness, feeling of well-being |
|
|
Term
|
Definition
| Relaxation, happy, mild motor impairment |
|
|
Term
|
Definition
| consciousness impaired and unresponsive |
|
|
Term
|
Definition
| most common type of seizure. consciousness impaired; initial contraction of muscles (tonic phase) followed by rhythmic contractions (clonic phase) |
|
|
Term
|
Definition
| Sudden brief herky jerky movements ofm uscles. no paralysis, no loss of awareness or consciousness. |
|
|
Term
|
Definition
| Lose all muscle tone and just collapse. theres a disturbance in cosciousness as well. |
|
|
Term
|
Definition
| Treatment of psychomotor and tonic-clonic epilepsies |
|
|
Term
|
Definition
| Treatment of psychomotor epilepsy |
|
|
Term
|
Definition
| Pro drug turns into pehnobarbital and phenlethylmalonamide. treatment of psychomotor epilepsy and psychomotor and tonic-clonic epilepsies |
|
|
Term
|
Definition
| treatment of absence and myoclonic epilepsies |
|
|
Term
|
Definition
| treatment of status epilepticus |
|
|
Term
|
Definition
| Treatment of psychomotor and tonic-clinc epilepsies. treatment of trigeminal and facial neuralgias |
|
|
Term
|
Definition
| Treatment of psychomotor, tonic-clonic absence of mycolonic epilepsies |
|
|
Term
| Ethosuximide, Trimethadione |
|
Definition
| Treatment of petitmal epilepsy |
|
|
Term
|
Definition
| Centrally acting GABA agonist |
|
|
Term
|
Definition
| Positive modulateor of GABA receptors |
|
|
Term
|
Definition
| Inhibitor of GABA reuptake |
|
|
Term
|
Definition
| NA channel blocker but may also block voltage-activated Ca++ |
|
|
Term
|
Definition
| Inhibit spread of electrical activity by unknown mechanism |
|
|
